Literature DB >> 16959384

Study of the serological response after vaccination against tick-borne encephalitis in Sweden.

Sirkka Vene1, Mats Haglund, Ake Lundkvist, Lars Lindquist, Marianne Forsgren.   

Abstract

The antibody response to vaccination against tick-borne encephalitis (TBE) with FSME-Immun Inject (Immuno AG/Baxter) was studied in 535 persons, mainly adults, attending a vaccination centre in Stockholm, Sweden. Emphasis was laid on long-term follow-up. Antibody activity was measured by three different serological test systems: a commercial ELISA kit, a hemagglutination inhibition (HI) test and a neutralization test (RFFIT). The neutralization test proved to be the most sensitive assay for the detection of the vaccine response, which was demonstrable in the majority of vaccinees (>90% after three and >98% after four and five vaccinations, respectively). ELISA and HI were less sensitive for antibody measurement during primary immunization. Neutralizing antibody activity persisted prior to the third dose in 77% of the vaccinees and prior to the fourth to sixth doses in 89-95% of the vaccinees. ELISA activity, but no neutralizing activity, was found in some individuals. Based on our data and previous experience of vaccine failures after two doses, a more condensed three-dose vaccination schedule may be advantageous and ought to be tested. The persistence of neutralizing antibodies justifies further studies of the antibody responses after the fourth dose for periods beyond the recommended 3-year booster intervals.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16959384     DOI: 10.1016/j.vaccine.2006.07.026

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Comparison of Two Commercial Tick-Borne Encephalitis Virus IgG Enzyme-Linked Immunosorbent Assays.

Authors:  Fabian H Weissbach; Hans H Hirsch
Journal:  Clin Vaccine Immunol       Date:  2015-04-29

2.  Human Sera Collected between 1979 and 2010 Possess Blocking-Antibody Titers to Pandemic GII.4 Noroviruses Isolated over Three Decades.

Authors:  Sumit Sharma; Beatrice Carlsson; Rita Czakó; Sirkka Vene; Mats Haglund; Johnny Ludvigsson; Göran Larson; Lennart Hammarström; Stanislav V Sosnovtsev; Robert L Atmar; Kim Y Green; Mary K Estes; Lennart Svensson
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

3.  Low coverage and predictors of vaccination uptake against tick-borne encephalitis in Slovenia.

Authors:  Marta Grgic-Vitek; Irena Klavs
Journal:  Eur J Public Health       Date:  2011-03-11       Impact factor: 3.367

Review 4.  Vaccines for preventing tick-borne encephalitis.

Authors:  Vittorio Demicheli; Maria Grazia Debalini; Alessandro Rivetti
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21

Review 5.  Tick-borne encephalitis in pregnant women: A mini narrative review.

Authors:  E Bjonholm; S Soderholm; O Stephansson; H H Askling
Journal:  New Microbes New Infect       Date:  2022-08-29

6.  Factors determining immunological response to vaccination against tick-borne encephalitis virus in older individuals.

Authors:  Pontus Lindblom; Peter Wilhelmsson; Linda Fryland; Andreas Matussek; Mats Haglund; Johanna Sjöwall; Sirkka Vene; Dag Nyman; Pia Forsberg; Per-Eric Lindgren
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

7.  Distinction between serological responses following tick-borne encephalitis virus (TBEV) infection vs vaccination, Sweden 2017.

Authors:  Bo Albinsson; Sirkka Vene; Lars Rombo; Jonas Blomberg; Åke Lundkvist; Bengt Rönnberg
Journal:  Euro Surveill       Date:  2018-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.